Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers
Blueprint Medicines Corporation
Recent Podcasts
- December 2, 2024 | A discussion about QuidelOrthoCQ™ with Karen Taylor, Vice President, Customer Experience at QuidelOrtho
- July 9, 2024 | LATEST DATA: How evidence-based products can lower the risk of SSI for patients – Podcast
- May 16, 2024 | Leveraging Sustainable Practices in Healthcare Manufacturing
- May 15, 2024 | David Hargraves discusses best practices for servicing acute and non-acute sites
- December 21, 2023 | How Healthcare Providers are Shifting Toward Home Care